FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF BUSPIRONE USING COPROCESSED SUPERDISINTEGRANTS
Objective: The present study aims to formulate and evaluate Fast dissolving tablet of Buspirone, the drug that is used for management of anxiety, by direct compression method using various Super disintegrants.
Methods: Ten formulations (F1-F10) of fast dissolving tablets of Buspirone were prepared by using various Superdisintegrants. The prepared tablets were evaluated for hardness, friability, thickness, drug content uniformity, water absorption, wetting time, and disintegration time and in vitro dissolution study.
Results: Among all the formulations, F10 (containing 5 mg of Coprocessed (CS: SSG 1:2) Superdisintegrants) was considered to be the best formulation, which released up to 98% drug in 20 min as compared to a marketed conventional dosage form which dissolves in approx 60 min. The results of stability study of formulation F10 after a period of two months indicated that the formulation was stable.
Conclusion: It was concluded that a fast-dissolving tablet of Buspirone containing various Superdisintegrants is better and effective to meet patient compliance.
2. Habib W, Khankari R, Hontz J. Fast-dissolve drug delivery systems. Critical Rev Ther Drug Carrier Systems 2000;17:61-72.
3. Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 2006;7:E167-E175.
4. Madan J, Sharma AK, Singh R. Fast dissolving tablets of aloe vera gel. Trop J Pharm Res 2009;8:63-70.
5. Shu T, Suzuki H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull 2002;50:193-8.
6. https://www.drugbank.ca/drugs/DB00490. [Last accessed on 10 Mar 2019].
7. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Preparation and assessment of novel co-processed super disintegrant consisting of crospovidone and sodium starch glycolate: a technical note. AAPS PharmSciTech 2007;8:E63-E69.
8. Dobetti L. Fast-melting tablets: developments and technologies. Pharm Technol 2001;2:44-50.
9. Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, IIDA K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chemical and pharmaceutical bulletin 1996;44:2121-7.
10. Yeole PG, Galgatte UC, Babla IB, Nakhat PD. Design and evaluation of xanthan gum-based sustained release matrix tablets of diclofenac sodium. Indian J Pharm Sci 2006;68:185-9.
11. Arora P, Sethi VA. Orodispersible tablets: a comprehensive review. Int J Res Dev Pharm Life Sci 2013;2:270-84.
12. Banker GS, Anderson NR. Tablets. Theory Practice Industrial Pharm 1987;3:293-345.
13. Nawale RB, Mohite KP. Formulation and evaluation of domperidone orodispersible tablet. Tablet 2013;15:21.
14. Bandari S, Rajendar Kumar Mitta Palli, Ramesh Gannu, Yamsani Madhusudan Rao. Orodispersible tablets: an overview. Asian J Pharm 2008;2:2-6.
15. Nayak AK, Manna K. Current developments in orally disintegrating tablet technology. J Pharm Edu Res 2011;2:21.
16. Dufresne S, Leblond H, Chaunet M. Relationship between lumen diameter and length sterilized in the 125L ozone sterilizer. Am J Infection Control 2008;36:291-7.
17. Indian Pharmacopoeia. 4th ed. New Delhi: The Controller of Publications; 1996. p. 735-6.
18. United State Pharmacopoeia. Convention. NF Asian edition; 2004. p. 74-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.